… Development of idiosyncratic hepatotoxicity is an intricate process … drug and host related
factors that are associated with an increased risk of antituberculous drug-induced hepatotoxicity…

… for the treatment of TB is a combination of anti-tuberculosis drugs (… treatment, adverse drug
reactions (ADRs) including the development of anti-tuberculosis drug-induced hepatotoxicity (…

… In conclusion, in our experience and with the limitations described, the risk factors for
hepatotoxicity due to anti-tuberculosis drugs, apart from their frequency, increased the severity of …

… performed on a monthly basis after the initiation of anti-TB treatment. For this study, hepatotoxicity
due to anti-TB drug treatment was defined as the following criteria: 1) serum aspartate …

… different retreatment protocols on hepatotoxicity recurrence in tuberculosis treatment. …
hepatotoxicity after anti-tuberculosis treatment. Patients in Group I (n 20) were retreated with a drug …

… normal value), hepatitis florida is the usual clinical … anti-tuberculosis drugs are responsible
for around 5% of all ALF, the second main cause after viral hepatitis (particularly viral hepatitis …

… Of the first-line anti-tuberculosis drugs, isoniazid (INH), … are all hepatotoxic and increase
the risk of hepatotoxicity when used together.Hepatotoxicity during anti-tuberculosis treatment is …

… In the present study, the biochemical manifestations of liver toxicity caused by co-administration
of anti-TB drugs, rifampicin (RIF), isoniazid (INH) and pyrazinamide (PZA), in a sub-…

… B virus carrier status and nutritional status with ATT-induced hepatitis … hepatotoxicity were
prospectively studied. In addition 128 patients on anti-tuberculosis drugs without hepatotoxicity …

… drugs, and abnormal baseline serum alanine aminotransfrase and aspartate … anti-tuberculosis
drugs induced hepatotoxicity. Conclusion: Anti-tuberculosis drugs induced hepatotoxicity …